|
1.
|
A De SarroG De SarroAdverse reactions to
fluoroquinolones. an overview on mechanistic aspectsCurr Med
Chem8371384200111172695
|
|
2.
|
HC LinYY YangTH TsaiThe relationship
between endotoxemia and hepatic endocannabinoids in cirrhotic rats
with portal hypertensionJ
Hepatol5411451153201110.1016/j.jhep.2010.09.02621145843
|
|
3.
|
M ZhangG SongGY MinukEffects of hepatic
stimulator substance, herbal medicine, selenium/vitamin E, and
ciprofloxacin on cirrhosis in the
ratGastroenterology11011501155199610.1053/gast.1996.v110.pm86130048613004
|
|
4.
|
VE ReviglioMA HakimJK SongTP O’BrienEffect
of topical fluoroquinolones on the expression of matrix
metalloproteinases in the corneaBMC
Ophthalmol310200310.1186/1471-2415-3-1014529574
|
|
5.
|
C SharmaT VelpandianS Baskar SinghN Ranjan
BiswasR Bihari VajpayeeS GhoseEffect of fluoroquinolones on the
expression of matrix metalloproteinase in debrided cornea of
ratsToxicol Mech
Methods21612201110.3109/15376516.2010.52918321058936
|
|
6.
|
J BuytenG KaufmanM RyanEffects of
ciprofloxacin/dexamethasone and ofloxacin on tympanic membrane
perforation healingOtol
Neurotol28887890200710.1097/MAO.0b013e3180dca1a3
|
|
7.
|
WC TsaiCC HsuCP ChenCiprofloxacin
up-regulates tendon cells to express matrix metalloproteinase-2
with degradation of type I collagenJ Orthop
Res296773201110.1002/jor.2119620602464
|
|
8.
|
AN CorpsRL HarrallVA CurrySA FenwickBL
HazlemanGP RileyCiprofloxacin enhances the stimulation of matrix
metalloproteinase 3 expression by interleukin-1beta in human
tendon-derived cells. A potential mechanism of
fluoroquinolone-induced tendinopathyArthritis
Rheum4630343040200210.1002/art.10617
|
|
9.
|
AN CorpsRL HarrallVA CurryBL HazlemanGP
RileyContrasting effects of fluoroquinolone antibiotics on the
expression of the collagenases, matrix metalloproteinases (MMP)-1
and -13, in human tendon-derived cellsRheumatology
(Oxford)4415141517200510.1093/rheumatology/kei08716148020
|
|
10.
|
J SendzikM ShakibaeiM Schafer-KortingH
LodeR StahlmannSynergistic effects of dexamethasone and quinolones
on human-derived tendon cellsInt J Antimicrob
Agents35366374201010.1016/j.ijantimicag.2009.10.00920034766
|
|
11.
|
K GotoK YabeT SuzukiK TakasunaT JindoS
ManabeGene expression profiles in the articular cartilage of
juvenile rats receiving the quinolone antibacterial agent
ofloxacinToxicology249204213200810.1016/j.tox.2008.05.00518572299
|
|
12.
|
EC RubenVR ManuelOR AgustinM HuertaFM
AntonioDE IvanCiprofloxacin utility as antifibrotic in the skin of
patients with sclerodermaJ
Dermatol37323329201010.1111/j.1346-8138.2010.00826.x20507401
|
|
13.
|
AH TruongY Ben-DavidThe role of Fli-1 in
normal cell function and malignant
transformationOncogene1964826489200010.1038/sj.onc.120404211175364
|
|
14.
|
J Czuwara-LadykowskaF ShirasakiP JackersDK
WatsonM TrojanowskaFli-1 inhibits collagen type I production in
dermal fibroblasts via an Sp1-dependent pathwayJ Biol
Chem2762083920848200110.1074/jbc.M01013320011278621
|
|
15.
|
M KuboJ Czuwara-LadykowskaO
MoussaPersistent down-regulation of Fli1, a suppressor of collagen
transcription, in fibrotic scleroderma skinAm J
Pathol163571581200310.1016/S0002-9440(10)63685-112875977
|
|
16.
|
Y AsanoM MarkiewiczM KuboG SzalaiDK
WatsonM TrojanowskaTranscription factor Fli1 regulates collagen
fibrillogenesis in mouse skinMol Cell
Biol29425434200910.1128/MCB.01278-0819001092
|
|
17.
|
SS NakerakantiB KapanadzeM YamasakiM
MarkiewiczM TrojanowskaFli1 and Ets1 have distinct roles in
connective tissue growth factor/CCN2 gene regulation and induction
of the profibrotic gene programJ Biol
Chem2812525925269200610.1074/jbc.M60046620016829517
|
|
18.
|
P HainesGH SamuelH CohenM TrojanowskaAM
BujorCaveolin-1 is a negative regulator of MMP-1 gene expression in
human dermal fibroblasts via inhibition of Erk1/2/Ets1 signaling
pathwayJ Dermatol
Sci64210216201110.1016/j.jdermsci.2011.08.00521925842
|
|
19.
|
AM BujorS NakerakantiE MorrisFN HantM
TrojanowskaAkt inhibition up-regulates MMP1 through a
CCN2-dependent pathway in human dermal fibroblastsExp
Dermatol19347354201010.1111/j.1600-0625.2010.01065.x20201953
|
|
20.
|
S BuM YamanakaH PeiDihydrosphingosine
1-phosphate stimulates MMP1 gene expression via activation of
ERK1/2-Ets1 pathway in human fibroblastsFASEB
J20184186200616278291
|
|
21.
|
M JinninH IhnY MimuraY AsanoK YamaneK
TamakiMatrix metalloproteinase-1 up-regulation by hepatocyte growth
factor in human dermal fibroblasts via ERK signaling pathway
involves Ets1 and Fli1Nucleic Acids
Res3335403549200510.1093/nar/gki64815972796
|
|
22.
|
Y AsanoH IhnK YamaneM JinninY MimuraK
TamakiIncreased expression of integrin alpha(v)beta3 contributes to
the establishment of autocrine TGF-beta signaling in scleroderma
fibroblastsJ
Immunol17577087718200510.4049/jimmunol.175.11.770816301681
|
|
23.
|
Y MimuraH IhnM JinninY AsanoK YamaneK
TamakiEpidermal growth factor affects the synthesis and degradation
of type I collagen in cultured human dermal fibroblastsMatrix
Biol25202212200610.1016/j.matbio.2005.12.00216413767
|
|
24.
|
JB JunM KuechleJ MinScleroderma
fibroblasts demonstrate enhanced activation of Akt (protein kinase
B) in situJ Invest
Dermatol124298303200510.1111/j.0022-202X.2004.23559.x15675946
|
|
25.
|
AM BujorY AsanoP HainesR LafyatisM
TrojanowskaThe c-Abl tyrosine kinase controls protein kinase
Cdelta-induced Fli-1 phosphorylation in human dermal
fibroblastsArthritis
Rheum6317291737201110.1002/art.3028421321929
|
|
26.
|
J PannuY AsanoS NakerakantiSmad1 pathway
is activated in systemic sclerosis fibroblasts and is targeted by
imatinib mesylateArthritis
Rheum5825282537200810.1002/art.2369818668566
|
|
27.
|
Y MoriSJ ChenJ VargaExpression and
regulation of intracellular SMAD signaling in scleroderma skin
fibroblastsArthritis
Rheum4819641978200310.1002/art.1115712847691
|
|
28.
|
AM BujorJ PannuS BuEA SmithRC
Muise-HelmericksM TrojanowskaAkt blockade downregulates collagen
and upregulates MMP1 in human dermal fibroblastsJ Invest
Dermatol12819061914200810.1038/jid.2008.3918323784
|
|
29.
|
Y WangPS FanB KahalehAssociation between
enhanced type I collagen expression and epigenetic repression of
the FLI1 gene in scleroderma fibroblastsArthritis
Rheum5422712279200610.1002/art.2194816802366
|
|
30.
|
RJ Williams IIIE AttiaTL WickiewiczJA
HannafinThe effect of ciprofloxacin on tendon, paratenon, and
capsular fibroblast metabolismAm J Sports
Med28364369200010843129
|
|
31.
|
WC TsaiCC HsuFT TangAM WongYC ChenJH
PangCiprofloxacin-mediated cell proliferation inhibition and G2/M
cell cycle arrest in rat tendon cellsArthritis
Rheum5816571663200810.1002/art.2351818512786
|
|
32.
|
WC TsaiCC HsuHC ChenCiprofloxacin-mediated
inhibition of tenocyte migration and down-regulation of focal
adhesion kinase phosphorylationEur J
Pharmacol6072326200910.1016/j.ejphar.2009.02.00619232343
|
|
33.
|
K TakedaA HatamochiH UekiM NakataY
OishiDecreased collagenase expression in cultured systemic
sclerosis fibroblastsJ Invest
Dermatol103359363199410.1111/1523-1747.ep123949368077701
|
|
34.
|
J ElkarehSM PeriyasamyA
ShidyakMarinobufagenin induces increases in procollagen expression
in a process involving protein kinase C and Fli-1: implications for
uremic cardiomyopathyAm J Physiol Renal
Physiol296F1219F1226200910.1152/ajprenal.90710.2008
|
|
35.
|
A SakthianandeswarenJM CurtisC ElsoFine
mapping of Leishmania major susceptibility Locus lmr2 and evidence
of a role for Fli1 in disease and wound healingInfect
Immun7827342744201010.1128/IAI.00126-1020368343
|
|
36.
|
D AbrahamConnective tissue growth factor:
growth factor, matricellular organizer, fibrotic biomarker or
molecular target for anti-fibrotic therapy in SSc?Rheumatology
(Oxford)47Suppl 5v8v9200810.1093/rheumatology/ken27818784153
|
|
37.
|
G FarinaR LemaireP PancariJ BayleRL WidomR
LafyatisCartilage oligomeric matrix protein expression in systemic
sclerosis reveals heterogeneity of dermal fibroblast responses to
transforming growth factor betaAnn Rheum
Dis68435441200910.1136/ard.2007.086850
|
|
38.
|
G FarinaD LafyatisR LemaireR LafyatisA
four-gene biomarker predicts skin disease in patients with diffuse
cutaneous systemic sclerosisArthritis
Rheum62580588201010.1002/art.2722020112379
|
|
39.
|
A HolmesDJ AbrahamS SaX ShiwenCM BlackA
LeaskCTGF and SMADs, maintenance of scleroderma phenotype is
independent of SMAD signalingJ Biol
Chem2761059410601200110.1074/jbc.M01014920011152469
|
